Similar articles for PMID: 25140906

Year	Number of Results
1998	1
1999	1
2000	4
2001	1
2002	2
2004	3
2005	3
2006	2
2007	3
2008	4
2009	4
2010	9
2011	8
2012	8
2013	7
2014	12
2015	8
2016	5
2017	8
2018	1
2019	4
2020	1
2021	5
2022	2
2024	0

1

Impact of adherence and anthropometric characteristics on nevirapine pharmacokinetics and exposure among HIV-infected Kenyan children.

Vreeman RC, Nyandiko WM, Liechty EA, Busakhala N, Bartelink IH, Savic RM, Scanlon ML, Ayaya SO, Blaschke TF. Vreeman RC, et al. J Acquir Immune Defic Syndr. 2014 Nov 1;67(3):277-86. doi: 10.1097/QAI.0000000000000300. J Acquir Immune Defic Syndr. 2014. PMID: 25140906

2

Pharmacokinetics-based adherence measures for antiretroviral therapy in HIV-infected Kenyan children.

Tu W, Nyandiko WM, Liu H, Slaven JE, Scanlon ML, Ayaya SO, Vreeman RC. Tu W, et al. J Int AIDS Soc. 2017 Jun 15;20(1):21157. doi: 10.7448/IAS.20.1.21157. J Int AIDS Soc. 2017. PMID: 28605170 Free PMC article.

3

Effect of First-Line Antituberculosis Therapy on Nevirapine Pharmacokinetics in Children Younger than Three Years Old.

Enimil A, Antwi S, Yang H, Dompreh A, Alghamdi WA, Gillani FS, Orstin A, Bosomtwe D, Opoku T, Norman J, Wiesner L, Langaee T, Peloquin CA, Court MH, Greenblatt DJ, Kwara A. Enimil A, et al. Antimicrob Agents Chemother. 2019 Sep 23;63(10):e00839-19. doi: 10.1128/AAC.00839-19. Print 2019 Oct. Antimicrob Agents Chemother. 2019. PMID: 31332062 Free PMC article.

4

Plasma nevirapine concentrations predict virological and adherence failure in Kenyan HIV-1 infected patients with extensive antiretroviral treatment exposure.

Kimulwo MJ, Okendo J, Aman RA, Ogutu BR, Kokwaro GO, Ochieng DJ, Muigai AW, Oloo FA, Ochieng W. Kimulwo MJ, et al. PLoS One. 2017 Feb 24;12(2):e0172960. doi: 10.1371/journal.pone.0172960. eCollection 2017. PLoS One. 2017. PMID: 28235021 Free PMC article.

5

Population pharmacokinetic and pharmacogenetic analysis of nevirapine in hypersensitive and tolerant HIV-infected patients from Malawi.

Dickinson L, Chaponda M, Carr DF, van Oosterhout JJ, Kumwenda J, Lalloo DG, Pirmohamed M, Heyderman RS, Khoo SH. Dickinson L, et al. Antimicrob Agents Chemother. 2014;58(2):706-12. doi: 10.1128/AAC.02069-13. Epub 2013 Nov 11. Antimicrob Agents Chemother. 2014. PMID: 24217698 Free PMC article.

6

Optimisation of antiretroviral therapy in HIV-infected children under 3 years of age.

Penazzato M, Prendergast AJ, Muhe LM, Tindyebwa D, Abrams E. Penazzato M, et al. Cochrane Database Syst Rev. 2014 May 22;2014(5):CD004772. doi: 10.1002/14651858.CD004772.pub4. Cochrane Database Syst Rev. 2014. PMID: 24852077 Free PMC article. Review.

7

Pharmacokinetics of nevirapine in HIV-infected children receiving an adult fixed-dose combination of stavudine, lamivudine and nevirapine.

Chokephaibulkit K, Plipat N, Cressey TR, Frederix K, Phongsamart W, Capparelli E, Kolladarungkri T, Vanprapar N. Chokephaibulkit K, et al. AIDS. 2005 Sep 23;19(14):1495-9. doi: 10.1097/01.aids.0000183625.97170.59. AIDS. 2005. PMID: 16135903

8

Pharmacogenetic predictors of nevirapine pharmacokinetics in Ghanaian children living with HIV with or without TB coinfection.

Langaee T, Al-Shaer MH, Gong Y, Lima E, Antwi S, Enimil A, Dompreh A, Yang H, Alghamdi WA, Wiesner L, Peloquin CA, Kwara A. Langaee T, et al. Infect Genet Evol. 2021 Aug;92:104856. doi: 10.1016/j.meegid.2021.104856. Epub 2021 Apr 8. Infect Genet Evol. 2021. PMID: 33839311 Free PMC article. Clinical Trial.

9

Population pharmacokinetics of nevirapine in an unselected cohort of HIV-1-infected individuals.

de Maat MM, Huitema AD, Mulder JW, Meenhorst PL, van Gorp EC, Beijnen JH. de Maat MM, et al. Br J Clin Pharmacol. 2002 Oct;54(4):378-85. doi: 10.1046/j.1365-2125.2002.01657.x. Br J Clin Pharmacol. 2002. PMID: 12392585 Free PMC article. Clinical Trial.

10

Population pharmacokinetics of nevirapine, zidovudine, and didanosine in human immunodeficiency virus-infected patients. The National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators.

Zhou XJ, Sheiner LB, D'Aquila RT, Hughes MD, Hirsch MS, Fischl MA, Johnson VA, Myers M, Sommadossi JP. Zhou XJ, et al. Antimicrob Agents Chemother. 1999 Jan;43(1):121-8. doi: 10.1128/AAC.43.1.121. Antimicrob Agents Chemother. 1999. PMID: 9869576 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year